Medicare Enrolled
Dr. Arjun Khosla, M.D.
Urology Physician · Broomall, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khosla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khosla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khosla
Dr. Arjun Khosla is an urology physician in Broomall, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Khosla performed 3,267 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Khosla received a total of $4,004 from 43 pharmaceutical and/or device companies across 207 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khosla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 19% volume in PA
$4,004 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,267
Medicare services
Top 19% in PA for urology physician
Not available
Unique patients (not deduplicated)
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
903 | $9 | $67 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
824 | $2 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
670 | $100 | $295 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
238 | $70 | $208 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
222 | $49 | $85 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 103 | $137 | $800 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
64 | $63 | $600 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
53 | $136 | $358 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
44 | $66 | $298 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
29 | $28 | $100 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
27 | $85 | $246 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $43 | $72 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $146 | $316 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
16 | $105 | $507 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
15 | $94 | $1,000 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
14 | $345 | $785 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.4% high complexity
28.5% medium
70.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,004
Total received (2018-2024)
Avg $572/year across 7 years
Top 33% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
207
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$866
2023
$594
2022
$725
2021
$496
2020
$275
2019
$569
2018
$479
Payments by company (2024)
Sumitomo Pharma America, Inc.
$153
ABBVIE INC.
$149
Janssen Biotech, Inc.
$104
Axonics, Inc.
$88
AstraZeneca Pharmaceuticals LP
$77
Dendreon Pharmaceuticals LLC
$69
Astellas Pharma US Inc
$65
PROCEPT BioRobotics Corporation
$33
Novartis Pharmaceuticals Corporation
$31
Boston Scientific Corporation
$25
Telix Pharmaceuticals
$20
Tolmar, Inc.
$19
Ferring Pharmaceuticals Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Top 3 companies account for 46.9% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$714
Janssen Biotech, Inc.
$522
Axonics, Inc.
$393
Myovant Sciences Inc.
$238
Sumitomo Pharma America, Inc.
$221
Dendreon Pharmaceuticals LLC
$182
ABBVIE INC.
$167
Teleflex LLC
$161
Ferring Pharmaceuticals Inc.
$133
PFIZER INC.
$128
Bayer HealthCare Pharmaceuticals Inc.
$106
Bayer Healthcare Pharmaceuticals Inc.
$82
AstraZeneca Pharmaceuticals LP
$77
UROVANT SCIENCES INC
$71
Clarus Therapeutics Inc.
$67
Blue Earth Diagnostics Limited
$66
Avadel Specialty Pharmaceuticals, LLC
$58
Boston Scientific Corporation
$46
Coloplast Corp
$35
Antares Pharma, Inc.
$34
PROCEPT BioRobotics Corporation
$33
Merck Sharp & Dohme LLC
$33
Kowa Pharmaceuticals America, Inc.
$32
Acerus Pharmaceuticals Corporation
$32
Merck Sharp & Dohme Corporation
$31
Novartis Pharmaceuticals Corporation
$31
Endo Pharmaceuticals Inc.
$29
Sun Pharmaceutical Industries Inc.
$27
NeoTract Inc.
$26
Baxter Healthcare
$22
TOLMAR Pharmaceuticals, Inc.
$21
BAXTER HEALTHCARE
$20
Telix Pharmaceuticals
$20
C. R. BARD, INC. & SUBSIDIARIES
$20
Tolmar, Inc.
$19
Amgen Inc.
$18
GENZYME CORPORATION
$18
MEDIVATION FIELD SOLUTIONS LLC
$15
Myriad Genetic Laboratories, Inc.
$14
Sagent Pharmaceuticals, Inc.
$13
AbbVie, Inc.
$12
Mission Pharmacal Company
$12
Aytu BioScience, Inc
$10
Top 3 companies account for 40.7% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AQUABEAM SYSTEM · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bulkamid · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLOSEAL · GEMTESA · Glydo · ILLUCCIX · JATENZO · JEVTANA · KEYTRUDA · LITHOVUE · LYNPARZA · MYRBETRIQ · Myrbetriq · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · PLUVICTO · POSLUMA · PROVENGE · Prolaris · Prolia · Rezum Generator · SEGLENTIS · SPEEDICATH · TISSEEL · UROLIFT · Uribel · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
294
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
BRYN MAWR HOSPITAL
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khosla is a clinical cardiology specialist, with above-average Medicare volume (top 19% in PA), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khosla experienced with bladder ultrasound after voiding?
Based on Medicare claims data, Dr. Khosla performed 903 bladder ultrasound after voiding services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Khosla receive payments from pharmaceutical companies?
Yes. Dr. Khosla received a total of $4,004 from 43 companies across 207 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khosla's costs compare to other urology physicians in Broomall?
Dr. Khosla's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khosla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Broomall
Browse urology physicians in Broomall ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology